Tumor biomarkers that identify molecular subtypes and best responders to chemotherapy in patients with PDAC
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Heidelberg, Universität Heidelberg, Dissertation, 2023
- Keyword
-
Bauchspeicheldrüsenkrebs
Krebs
Therapie
Bauchspeicheldrüsenkrankheit
- Event
-
Veröffentlichung
- (where)
-
Heidelberg
- (who)
-
Universitätsbibliothek Heidelberg
- (when)
-
2023
- Creator
- Contributor
- DOI
-
10.11588/heidok.00032941
- URN
-
urn:nbn:de:bsz:16-heidok-329416
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhou, Xu
- Fortunato, Franco
- Universitätsbibliothek Heidelberg
Time of origin
- 2023
Other Objects (12)
PDAC-Automobilclub
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC
Patient-specific heart simulation can identify non-responders to cardiac resynchronization therapy
Integrating heterogeneous genomic data to accurately identify disease subtypes
Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
Usefulness of NT-pro BNP monitoring to identify echocardiographic responders following cardiac resynchronization therapy
Therapeutic strategies targeting Kv10.1 in PDAC
PDAC: Profitieren Hochrisikoindividuen von einer Langzeitüberwachung?
PDAC: Profitieren Hochrisikoindividuen von einer Langzeitüberwachung?
Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders
PDAC-Automobilclub
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC
Patient-specific heart simulation can identify non-responders to cardiac resynchronization therapy
Integrating heterogeneous genomic data to accurately identify disease subtypes
Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
Usefulness of NT-pro BNP monitoring to identify echocardiographic responders following cardiac resynchronization therapy
Therapeutic strategies targeting Kv10.1 in PDAC
PDAC: Profitieren Hochrisikoindividuen von einer Langzeitüberwachung?
PDAC: Profitieren Hochrisikoindividuen von einer Langzeitüberwachung?
Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders
PDAC-Automobilclub
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC
Patient-specific heart simulation can identify non-responders to cardiac resynchronization therapy
Integrating heterogeneous genomic data to accurately identify disease subtypes
Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
Usefulness of NT-pro BNP monitoring to identify echocardiographic responders following cardiac resynchronization therapy
Therapeutic strategies targeting Kv10.1 in PDAC
PDAC: Profitieren Hochrisikoindividuen von einer Langzeitüberwachung?
PDAC: Profitieren Hochrisikoindividuen von einer Langzeitüberwachung?